Pyry A J Välitalo1, Koen Griffioen1, Matthew L Rizk2, Sandra A G Visser2, Meindert Danhof1, Gaori Rao3, Piet H van der Graaf1, J G Coen van Hasselt4. 1. Division of Pharmacology, Cluster Systems Pharmacology, Leiden Academic Centre for Drug Research (LACDR), Faculty of Science, Leiden University, Einsteinweg 55, 2333 CC, Leiden, Netherlands. 2. Merck & Co. Inc., Kenilworth, New Jersey, USA. 3. University at Buffalo, Buffalo, New York, USA. 4. Division of Pharmacology, Cluster Systems Pharmacology, Leiden Academic Centre for Drug Research (LACDR), Faculty of Science, Leiden University, Einsteinweg 55, 2333 CC, Leiden, Netherlands. jgc.vanhasselt@gmail.com.
Abstract
PURPOSE: Obtaining pharmacologically relevant exposure levels of antibiotics in the epithelial lining fluid (ELF) is of critical importance to ensure optimal treatment of lung infections. Our objectives were to develop a model for the prediction of the ELF-plasma concentration ratio (EPR) of antibiotics based on their chemical structure descriptors (CSDs). METHODS: EPR data was obtained by aggregating ELF and plasma concentrations from historical clinical studies investigating antibiotics and associated agents. An elastic net regularized regression model was used to predict EPRs based on a large number of CSDs. The model was tuned using leave-one-drug-out cross validation, and the predictions were further evaluated using a test dataset. RESULTS: EPR data of 56 unique compounds was included. A high degree of variability in EPRs both between- and within drugs was apparent. No trends related to study design or pharmacokinetic factors could be identified. The model predicted 80% of the within-drug variability (R(2) WDV) and 78.6% of drugs were within 3-fold difference from the observations. Key CSDs were related to molecular size and lipophilicity. When predicting EPRs for a test dataset the R(2) WDV was 75%. CONCLUSIONS: This model is of relevance to inform dose selection and optimization during antibiotic drug development of agents targeting lung infections.
PURPOSE: Obtaining pharmacologically relevant exposure levels of antibiotics in the epithelial lining fluid (ELF) is of critical importance to ensure optimal treatment of lung infections. Our objectives were to develop a model for the prediction of the ELF-plasma concentration ratio (EPR) of antibiotics based on their chemical structure descriptors (CSDs). METHODS: EPR data was obtained by aggregating ELF and plasma concentrations from historical clinical studies investigating antibiotics and associated agents. An elastic net regularized regression model was used to predict EPRs based on a large number of CSDs. The model was tuned using leave-one-drug-out cross validation, and the predictions were further evaluated using a test dataset. RESULTS: EPR data of 56 unique compounds was included. A high degree of variability in EPRs both between- and within drugs was apparent. No trends related to study design or pharmacokinetic factors could be identified. The model predicted 80% of the within-drug variability (R(2) WDV) and 78.6% of drugs were within 3-fold difference from the observations. Key CSDs were related to molecular size and lipophilicity. When predicting EPRs for a test dataset the R(2) WDV was 75%. CONCLUSIONS: This model is of relevance to inform dose selection and optimization during antibiotic drug development of agents targeting lung infections.
Authors: Seth T Housman; J Samuel Pope; John Russomanno; Edward Salerno; Eric Shore; Joseph L Kuti; David P Nicolau Journal: Antimicrob Agents Chemother Date: 2012-02-13 Impact factor: 5.191
Authors: Yoke-Lin Lo; Johan G C van Hasselt; Siow-Chin Heng; Chin-Theam Lim; Toong-Chow Lee; Bruce G Charles Journal: Antimicrob Agents Chemother Date: 2010-04-12 Impact factor: 5.191
Authors: Emmanuel Boselli; Dominique Breilh; Sarah Djabarouti; Christian Guillaume; Thomas Rimmelé; Jean-Baptiste Gordien; Fabien Xuereb; Marie-Claude Saux; Bernard Allaouchiche Journal: Intensive Care Med Date: 2007-05-25 Impact factor: 17.440
Authors: J G Coen van Hasselt; Matthew L Rizk; Mallika Lala; Cynthia Chavez-Eng; Sandra A G Visser; Thomas Kerbusch; Meindert Danhof; Gauri Rao; Piet H van der Graaf Journal: Br J Clin Pharmacol Date: 2016-04-01 Impact factor: 4.335
Authors: Ute Chiriac; Otto R Frey; Anka C Roehr; Andreas Koeberer; Patrick Gronau; Thomas Fuchs; Jason A Roberts; Alexander Brinkmann Journal: Medicine (Baltimore) Date: 2021-06-04 Impact factor: 1.817
Authors: Linda B S Aulin; Pyry A Valitalo; Matthew L Rizk; Sandra A G Visser; Gauri Rao; Piet H van der Graaf; J G Coen van Hasselt Journal: Pharm Res Date: 2018-01-08 Impact factor: 4.200
Authors: Matthew L Rizk; Elizabeth G Rhee; Patricia A Jumes; Mark H Gotfried; Tian Zhao; Eric Mangin; Sheng Bi; Cynthia M Chavez-Eng; Zufei Zhang; Joan R Butterton Journal: Antimicrob Agents Chemother Date: 2018-02-23 Impact factor: 5.191
Authors: Lloyd Tanner; Gabriel T Mashabela; Charles C Omollo; Timothy J de Wet; Christopher J Parkinson; Digby F Warner; Richard K Haynes; Lubbe Wiesner Journal: Microbiol Spectr Date: 2021-09-29